Table 3.
Selected clinical studies on hops.
| Disease/condition or observed effect | Dosage form | References |
|---|---|---|
| Hops | ||
| quality of sleep | standardized extracts of Valeriana officinalis, Passiflora incarnate, and Humulus lupulus | Maroo et al., 2013 |
| linolenic and linoleic acids in association with Humulus lupulus extract. | Cornu et al., 2010 | |
| valerian/hop extract combination | Müller-Limmroth and Ehrenstein, 1977; Koetter et al., 2007; Dimpfel and Suter, 2008 | |
| Vigilance | tablets containing valerian and hops | Gerhard et al., 1996 |
| menopausal symptoms | hop extract | Erkkola et al., 2010; van Breemen et al., 2020 |
| hop tablets | Aghamiri et al., 2016 | |
| appetite suppression | hop flower extract suspended in canola oil | Walker et al., 2019 |
| body fat | matured hop extract | Morimoto-Kobayashi et al., 2016; Suzuki et al., 2018 |
| dental plaque regrowth | hop bract polyphenols | Shinada et al., 2007 |
| clinical safety and efficacy | combination of iso-alpha acids from hops, rosemary, and oleanolic acid | Minich et al., 2007 |
| self-reported depression, anxiety, and stress levels | dry hop extract | Kyrou et al., 2017 |
| overactive bladder | combination of seed oil from Uromedic pumpkin, Rhus aromatica (bark extract, and hop cone extract) | Gauruder-Burmester et al., 2019 |
| intestinal conversion of isoxanthohumol in 8-prenylnaringenin | dose of isoxanthohumol | Possemiers et al., 2006 |
| endothelial functions | isomerized hop extract | Tomita et al., 2017 |